IRIS Accounts Production v25.1.4.42 11584266 Board of Directors 1.6.24 31.5.25 31.5.25 false true false false false true false Ordinary 0.010 A Ordinary 0.10000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh115842662024-05-31115842662025-05-31115842662024-06-012025-05-31115842662023-09-30115842662023-10-012024-05-31115842662024-05-3111584266ns15:EnglandWales2024-06-012025-05-3111584266ns14:PoundSterling2024-06-012025-05-3111584266ns10:Director12024-06-012025-05-3111584266ns10:PrivateLimitedCompanyLtd2024-06-012025-05-3111584266ns10:SmallEntities2024-06-012025-05-3111584266ns10:AuditExempt-NoAccountantsReport2024-06-012025-05-3111584266ns10:SmallCompaniesRegimeForDirectorsReport2024-06-012025-05-3111584266ns10:SmallCompaniesRegimeForAccounts2024-06-012025-05-3111584266ns10:FullAccounts2024-06-012025-05-311158426612024-06-012025-05-3111584266ns10:OrdinaryShareClass12024-06-012025-05-3111584266ns10:OrdinaryShareClass22024-06-012025-05-3111584266ns10:Director22024-06-012025-05-3111584266ns10:Director32024-06-012025-05-3111584266ns10:Director42024-06-012025-05-3111584266ns10:RegisteredOffice2024-06-012025-05-3111584266ns5:CurrentFinancialInstruments2025-05-3111584266ns5:CurrentFinancialInstruments2024-05-3111584266ns5:Non-currentFinancialInstruments2025-05-3111584266ns5:Non-currentFinancialInstruments2024-05-3111584266ns5:ShareCapital2025-05-3111584266ns5:ShareCapital2024-05-3111584266ns5:SharePremium2025-05-3111584266ns5:SharePremium2024-05-3111584266ns5:FurtherSpecificReserve1ComponentTotalEquity2025-05-3111584266ns5:FurtherSpecificReserve1ComponentTotalEquity2024-05-3111584266ns5:FurtherSpecificReserve2ComponentTotalEquity2025-05-3111584266ns5:FurtherSpecificReserve2ComponentTotalEquity2024-05-3111584266ns5:RetainedEarningsAccumulatedLosses2025-05-3111584266ns5:RetainedEarningsAccumulatedLosses2024-05-3111584266ns5:IntangibleAssetsOtherThanGoodwill2024-06-012025-05-3111584266ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-06-012025-05-3111584266ns5:PlantMachinery2024-06-012025-05-3111584266ns5:IntangibleAssetsOtherThanGoodwill2024-05-3111584266ns5:IntangibleAssetsOtherThanGoodwill2025-05-3111584266ns5:IntangibleAssetsOtherThanGoodwill2024-05-3111584266ns5:PlantMachinery2024-05-3111584266ns5:PlantMachinery2025-05-3111584266ns5:PlantMachinery2024-05-3111584266ns5:WithinOneYearns5:CurrentFinancialInstruments2025-05-3111584266ns5:WithinOneYearns5:CurrentFinancialInstruments2024-05-3111584266ns5:CurrentFinancialInstruments2024-06-012025-05-3111584266ns5:Non-currentFinancialInstruments2024-06-012025-05-3111584266ns10:OrdinaryShareClass12025-05-3111584266ns10:OrdinaryShareClass22025-05-31
REGISTERED NUMBER: 11584266 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 May 2025

for

Ampersand Health Limited

Ampersand Health Limited (Registered number: 11584266)






Contents of the Financial Statements
for the Year Ended 31 May 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Ampersand Health Limited

Company Information
for the Year Ended 31 May 2025







DIRECTORS: N Alaghband
G C Parkes
J S Synett
M C Jamieson





REGISTERED OFFICE: 4 Lonsdale Road
London
NW6 6RD





REGISTERED NUMBER: 11584266 (England and Wales)





ACCOUNTANTS: Shaw Accounting Services Limited
14 Amherst Avenue
London
W13 8NQ

Ampersand Health Limited (Registered number: 11584266)

Balance Sheet
31 May 2025

31.5.25 31.5.24
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 1,044,542 1,283,866
Tangible assets 5 257 2,227
1,044,799 1,286,093

CURRENT ASSETS
Debtors 6 50,844 48,018
Cash at bank 19,533 3,974
70,377 51,992
CREDITORS
Amounts falling due within one year 7 288,773 428,335
NET CURRENT LIABILITIES (218,396 ) (376,343 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

826,403

909,750

CREDITORS
Amounts falling due after more than one
year

8

21,143

15,955
NET ASSETS 805,260 893,795

CAPITAL AND RESERVES
Called up share capital 9 9 8
Share premium 5,197,370 4,695,886
Option monies received 42,250 42,250
Convertible loans - 150,000
Retained earnings (4,434,369 ) (3,994,349 )
SHAREHOLDERS' FUNDS 805,260 893,795

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Ampersand Health Limited (Registered number: 11584266)

Balance Sheet - continued
31 May 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 19 June 2025 and were signed on its behalf by:





N Alaghband - Director


Ampersand Health Limited (Registered number: 11584266)

Notes to the Financial Statements
for the Year Ended 31 May 2025

1. STATUTORY INFORMATION

Ampersand Health Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Development costs are being amortised evenly over their estimated useful life of five years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Ampersand Health Limited (Registered number: 11584266)

Notes to the Financial Statements - continued
for the Year Ended 31 May 2025

2. ACCOUNTING POLICIES - continued

Going concern
The Company is reliant upon further funding which is expected to be provided at a date after the financial statements are approved. However, if for any reason such funding is not forthcoming on a timetable which will enable the Company to meet its cash requirements and liabilities, further steps will need to be taken by the Company including potentially insolvency.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2024 - 7 ) .

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1 June 2024 3,254,258
Additions 275,409
At 31 May 2025 3,529,667
AMORTISATION
At 1 June 2024 1,970,392
Charge for year 514,733
At 31 May 2025 2,485,125
NET BOOK VALUE
At 31 May 2025 1,044,542
At 31 May 2024 1,283,866

The directors consider that the Intellectual Property, currently stated in the balance sheet at net book value, is undervalued.

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 June 2024
and 31 May 2025 18,600
DEPRECIATION
At 1 June 2024 16,373
Charge for year 1,970
At 31 May 2025 18,343
NET BOOK VALUE
At 31 May 2025 257
At 31 May 2024 2,227

Ampersand Health Limited (Registered number: 11584266)

Notes to the Financial Statements - continued
for the Year Ended 31 May 2025

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.5.25 31.5.24
£    £   
Trade debtors 35,956 33,102
Other debtors 14,888 14,916
50,844 48,018

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.5.25 31.5.24
£    £   
Bank loans and overdrafts 28,196 -
Trade creditors 146,894 157,202
Taxation and social security 12,544 42,084
Other creditors 101,139 229,049
288,773 428,335



8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.5.25 31.5.24
£    £   
Bank loans 5,188 -
Other creditors 15,955 15,955
21,143 15,955

The Other Creditor is represented by a loan to the company. This loan is interest free and will convert to Share Capital when certain events occur or targets are met.

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.5.25 31.5.24
value: £    £   
41,210 Ordinary £0.0001p 4 3
500 A Ordinary £0.1000p 5 5
9 8

During the year, Convertible Loan Notes with a nominal value of £525,000 were converted into Ordinary Shares of £0.0001 each, at a conversion price of £36.56 per share. The conversion resulted in the issue of new Ordinary Shares and gave rise to a share premium of £524,999, which has been credited to the share premium account.